Results 211 to 220 of about 1,346,074 (337)

The interstitial lung disease patient pathway: from referral to diagnosis. [PDF]

open access: yesERJ Open Res
Lough G   +32 more
europepmc   +1 more source

Inhalational Therapy For Chronic Lung Disease [PDF]

open access: bronze, 1962
Maurice S. Segal   +2 more
openalex   +1 more source

Occupational Lung Disease

open access: yesCanadian Journal of Respiratory, Critical Care, and Sleep Medicine, 2012
openaire   +3 more sources

Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Objectives This study sought to evaluate proteomic, metabolomic, and immune signatures in the cerebrospinal fluid of individuals with Down Syndrome Regression Disorder (DSRD). Methods A prospective case–control study comparing proteomic, metabolomic, and immune profiles in individuals with DSRD was performed.
Jonathan D. Santoro   +12 more
wiley   +1 more source

Serum enzymes in disease. XI. Glycolytic and oxidative enzymes and transaminases in patients with cancer of the lung [PDF]

open access: bronze, 1962
Michael West   +3 more
openalex   +1 more source

Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Cases of myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) co‐occurring with neoplasms have been reported. In this international, retrospective cohort study in South Korea and the USA, 16 of 445 (3.6%) patients with MOGAD had concurrent neoplasm within 2 years of MOGAD onset, resulting in a standardized incidence ...
Young Nam Kwon   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy